<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/0c7ee232-6a0a-4627-a067-84a12abe9176/5504433C-CD8E-43B1-9C87-2812BCC5459A/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.forbes.com/markets/2008/07/17/novartis-profits-forecast-markets-equity-cx_je_0717markets15.html" href="http://www.forbes.com/markets/2008/07/17/novartis-profits-forecast-markets-equity-cx_je_0717markets15.html" style="font-size: 11px;">www.forbes.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.forbes.com/markets/2008/07/17/novartis-profits-forecast-markets-equity-cx_je_0717markets15.html"><FONT>LONDON- - </FONT><SPAN class="lingo_region" id="lingo_span"> <P><DIV>A weak dollar and a saving program mean good bucks for drug maker <STRONG>Novartis</STRONG>. The Swiss firm posted an increase of 17.0% to $2.27 billion in second-quarter net profit, boosted by a weak dollar and its cost cutting program, beating forecasts and lifting its stock. </DIV> Shares in <B>Novartis</B> (nyse: <A class="maintkrlink" href="http://finapps.forbes.com/finapps/jsp/finance/compinfo/CIAtAGlance.jsp?tkr=NVS">NVS</A> - <A href="http://www.forbes.com/markets/company_news.jhtml?ticker=NVS"> news </A> - <A href="http://www.forbes.com/peopletracker/results.jhtml?startRow=0&name=&ticker=NVS"> people </A>) rose 0.9%, or 53 cents, to $56.95, in trading in New York, as investors were pleased of the robust shape of the company. </p> <P><DIV>"The weak dollar is helping Novartis' profits as they are counted in dollars and they have plenty of facilities in the U.S. where they produce at low price and then sell at high price in Europe," Guekam Arsene, an analyst with ESN Partner in Paris, told Forbes.com.</DIV></P></SPAN></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.forbes.com/markets/2008/07/17/novartis-profits-forecast-markets-equity-cx_je_0717markets15.html">Novartis High Solid Profit</blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/5504433C-CD8E-43B1-9C87-2812BCC5459A/blog/" title="blog or email this clip"><img src="http://content6.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

New from the makers of Clipmarks:  Amplify.com - Don't just share the news...Amplify it!